Hideo A Baba Selected Research

atrial natriuretic factor receptor A

1/2018	β Cell-specific deletion of guanylyl cyclase A, the receptor for atrial natriuretic peptide, accelerates obesity-induced glucose intolerance in mice.
1/2016	Endothelial Actions of ANP Enhance Myocardial Inflammatory Infiltration in the Early Phase After Acute Infarction.
9/2010	Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2.
5/2003	Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.
11/2002	Left but not right cardiac hypertrophy in atrial natriuretic peptide receptor-deficient mice is prevented by angiotensin type 1 receptor antagonist losartan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hideo A Baba Research Topics

Disease

22	Hepatocellular Carcinoma (Hepatoma) 12/2021 - 02/2006
21	Neoplasms (Cancer) 01/2022 - 12/2006
20	Fibrosis (Cirrhosis) 12/2021 - 11/2002
16	Heart Failure 11/2020 - 01/2002
11	Cardiomegaly (Heart Hypertrophy) 09/2010 - 11/2002
8	Inflammation (Inflammations) 01/2020 - 03/2003
8	Hypertrophy 04/2013 - 02/2003
4	Non-alcoholic Fatty Liver Disease 12/2021 - 12/2014
4	Infections 01/2020 - 01/2003
4	Neoplasm Metastasis (Metastasis) 01/2019 - 05/2008
4	Hypoxia (Hypoxemia) 03/2016 - 06/2002
4	Shock 02/2012 - 03/2003
4	Hypovolemia 06/2005 - 03/2003
3	Necrosis 12/2021 - 03/2003
3	Alcoholic Fatty Liver 12/2021 - 01/2013
3	Liver Diseases (Liver Disease) 01/2019 - 01/2014
3	Cholangiocarcinoma 05/2017 - 10/2014
3	Hepatitis 01/2017 - 02/2006
3	Cardiomyopathies (Cardiomyopathy) 09/2014 - 06/2004
3	Myocarditis (Carditis) 02/2014 - 01/2002
3	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 04/2013 - 01/2002
3	Hypertension (High Blood Pressure) 10/2005 - 11/2002
3	Multiple Organ Failure (MODS) 01/2005 - 03/2003
3	Endotoxemia 01/2005 - 03/2003
2	Pulmonary Hypertension 02/2022 - 03/2016
2	End Stage Liver Disease 09/2020 - 02/2009
2	Disease Progression 01/2020 - 01/2019
2	Liver Failure 01/2019 - 02/2009
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 02/2006
2	Obesity 01/2018 - 01/2010
2	Adenocarcinoma 05/2017 - 10/2015
2	Critical Illness (Critically Ill) 04/2016 - 03/2003
2	Reinfection 09/2015 - 03/2015
2	Heart Diseases (Heart Disease) 09/2014 - 06/2005
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 09/2014 - 11/2002
2	Ulcerative Colitis 02/2014 - 02/2009
2	Hemorrhage 10/2005 - 03/2003
1	Fabry Disease (Fabry's Disease) 05/2022
1	Type 2 Diabetes Mellitus (MODY) 12/2021
1	Giant Cell Tumors (Giant Cell Tumor) 01/2021
1	Alcoholic Hepatitis 01/2020

Drug/Important Bio-Agent (IBA)

12	Atrial Natriuretic Factor (ANF)IBA 02/2022 - 11/2002
12	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2005
11	Biomarkers (Surrogate Marker)IBA 01/2019 - 04/2010
9	Messenger RNA (mRNA)IBA 12/2021 - 11/2002
6	CollagenIBA 12/2021 - 11/2002
6	Phosphotransferases (Kinase)IBA 02/2017 - 08/2003
5	Transcription Factors (Transcription Factor)IBA 01/2020 - 02/2005
5	atrial natriuretic factor receptor AIBA 01/2018 - 11/2002
5	Matrix Metalloproteinases (MMPs)IBA 09/2010 - 02/2003
4	nasIBA 12/2021 - 01/2010
3	Natriuretic PeptidesIBA 01/2018 - 11/2004
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 04/2017 - 11/2007
3	Angiotensin IIIBA 03/2016 - 09/2010
3	Losartan (Cozaar)FDA LinkGeneric 03/2016 - 11/2002
3	Atrial Natriuretic Factor Receptors (Atrial Natriuretic Factor Receptor)IBA 09/2014 - 11/2002
3	Adrenergic Agents (Adrenergic Drugs)IBA 05/2012 - 02/2005
3	norfenefrineIBA 01/2005 - 03/2003
2	LipidsIBA 05/2022 - 01/2020
2	InterleukinsIBA 12/2021 - 05/2003
2	EnzymesIBA 12/2021 - 07/2011
2	EpitopesIBA 12/2021 - 12/2006
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 12/2021 - 10/2005
2	Biological ProductsIBA 01/2019 - 02/2006
2	SphingolipidsIBA 12/2017 - 01/2017
2	ProteomeIBA 03/2017 - 11/2016
2	Pharmaceutical PreparationsIBA 02/2017 - 12/2003
2	LigandsIBA 04/2016 - 11/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 05/2003
2	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 12/2013 - 09/2012
2	Freund's AdjuvantIBA 12/2013 - 09/2012
2	Contrast MediaIBA 12/2013 - 09/2012
2	Sirolimus (Rapamycin)FDA Link 09/2013 - 03/2009
2	Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA 04/2013 - 09/2010
2	Vasoconstrictor AgentsIBA 01/2005 - 03/2003
1	globotriaosylceramide (globotriosylceramide)IBA 05/2022
1	NucleotidesIBA 12/2021
1	Leucine (L-Leucine)FDA Link 12/2021
1	Keratin-18 (Keratin 18)IBA 12/2021
1	Nonesterified Fatty Acids (NEFA)IBA 12/2021
1	ImmunosorbentsIBA 12/2021
1	HMGB1 Protein (HMG1)IBA 12/2021
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 12/2021
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 12/2021
1	CaspasesIBA 12/2021
1	Ethanol (Ethyl Alcohol)IBA 12/2021
1	pexidartinibIBA 01/2021
1	ConnectinIBA 11/2020
1	Toll-Like Receptor 2IBA 01/2020
1	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 01/2020
1	lipoxin A4IBA 01/2020

Therapy/Procedure

14	Liver Transplantation 01/2022 - 02/2006
13	Therapeutics 01/2020 - 03/2003
11	Transplantation 04/2017 - 01/2002
9	Heart-Assist Devices 02/2011 - 01/2002
3	Heart Transplantation (Grafting, Heart) 02/2011 - 11/2005
2	Bariatric Surgery 12/2021 - 01/2010
2	Lung Transplantation 09/2013 - 01/2012
2	Drug Therapy (Chemotherapy) 08/2013 - 02/2009
1	Ligation 01/2020